Pilot Projects Program
试点项目计划
基本信息
- 批准号:10472653
- 负责人:
- 金额:$ 76.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-18 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAldosteroneAreaAwardCardiovascular DiseasesClinicalClinical ResearchCollaborationsCollectionCommunicable DiseasesCommunitiesCommunity OutreachCultural BackgroundsDataData CollectionDevelopmentDiabetes MellitusEconomically Deprived PopulationEndocrinologyExpenditureExtramural ActivitiesFacultyFundingGoalsGrantHealthHealth PrioritiesHealth Services AccessibilityHomeIndividualInfrastructureInstitutionKidney DiseasesLeadLearningMalignant NeoplasmsMaternal HealthMedical centerMentorsMineralocorticoidsMississippiMonitorNCI Scholars ProgramNamesObesityObesity associated diseaseOutcomePhasePilot ProjectsPopulation ResearchProbabilityProcessProgram DevelopmentRegulationResearchResearch PersonnelResearch Project GrantsResearch SupportResourcesReview LiteratureRoleRuralSeedsStudy SectionTimeTrainingTranslational ResearchUnited States National Institutes of HealthUniversitiesWorkbasecareercareer developmentclinical centercollegecommunity based participatory researchcommunity engaged researchcommunity engagementethnic diversityexpectationgender diversityhealth disparityimprovedinterestmedically underserved populationmeetingsmembermultidisciplinaryobesity managementoutreachprogramssuccesssummer institute
项目摘要
PROJECT SUMMARY- PILOT PROJECTS PROGRAM. Central to realizing the MCCTR's purpose of
expanding Mississippi's capacity for clinical, translational, and community research is its Pilot Projects Program
(PPP). The PPP supports clinical, translational, and population research projects that will become the basis for
competitive extramural funding applications. During Phase I, key considerations in awarding support to early
stage investigators included the (1) likelihood of attracting extramural funding, (2) evidence of a path toward an
independent research career for the applicant, and (3) probability that the research program would lead to
improved management of obesity or obesity-related diseases. Additional considerations included support for
ethnic and gender diversity, promoting multi-disciplinary and multi-institutional research projects, and equitable
distribution of resources across the MCCTR partner institutions. During Phase II, the breadth of PPP's initiatives
will be expanded in several ways. First, the focus of our pilot project awards will be expanded to include health
conditions such as obesity, diabetes, cardiovascular and renal disease, cancer, infectious diseases, and
maternal health, all of which are disproportionally prevalent in rural and economically disadvantaged areas of
our state. Second, the number of institutions of higher learning eligible to participate in open solicitation for
applications will be expanded to include Tougaloo College, University of Southern Mississippi, the University of
Mississippi Medical Center, and our new members, Mississippi State University and the University of Mississippi
in Oxford. Third, a new funding program that provides up to $5,000 in seed money to support multi-institutional
collaboration and preliminary data collection for development of a subsequent proposal to the PPP and
elsewhere will be introduced. The PPP will solicit applications for funding two times per year to support
investigator-initiated clinical and translational research of priority health areas within Mississippi, including
community-engaged research addressing Mississippi's health disparities and access-to-care issues, with the
expectation of funding up to seven pilot projects per year. Applications for the seed grant program will be solicited
four times per year through an expedited application and review process. For all programs, studies addressing
health disparities and medically underserved populations with an emphasis on implementation will be prioritized.
The PPP and its related programs will lead to support for multi-institutional and multi-disciplinary collaborative
research among strong investigators from diverse academic and cultural backgrounds. Overall, this approach
will lead to a broad-based, state-wide research platform that has the capacity to improve health outcomes and
address health disparities across Mississippi.
项目摘要 - 试点项目计划。实现 MCCTR 目标的核心
扩大密西西比州临床、转化和社区研究的能力是其试点项目计划
(购买力平价)。 PPP 支持临床、转化和人口研究项目,这些项目将成为以下项目的基础:
有竞争力的外部资金申请。在第一阶段,向早期提供支持的关键考虑因素
阶段调查人员包括(1)吸引外部资金的可能性,(2)通往
申请人的独立研究生涯,以及(3)该研究计划将带来的可能性
改善肥胖或肥胖相关疾病的管理。其他考虑因素包括支持
种族和性别多样性,促进多学科和多机构研究项目,以及公平
在 MCCTR 合作机构之间分配资源。在第二阶段,PPP 举措的广度
将以多种方式进行扩展。首先,我们试点项目奖励的重点将扩大到包括健康
肥胖、糖尿病、心血管和肾脏疾病、癌症、传染病等疾病
孕产妇保健,所有这些在农村和经济贫困地区尤为普遍
我们的国家。二、符合公开征集资格的高等院校数量
申请范围将扩大到包括图加卢学院 (Tougaloo College)、南密西西比大学 (University of Southern Mississippi)、
密西西比医学中心,以及我们的新成员,密西西比州立大学和密西西比大学
在牛津。第三,一项新的资助计划提供高达 5,000 美元的种子资金来支持多机构
合作和初步数据收集,以制定后续向 PPP 提出的提案
其他地方会介绍。 PPP 将每年两次征求资金申请,以支持
研究人员发起的密西西比州优先卫生领域的临床和转化研究,包括
社区参与的研究,解决密西西比州的健康差异和获得护理的问题,
预计每年资助最多七个试点项目。将征集种子资助计划的申请
通过快速申请和审查流程,每年四次。对于所有计划,研究都涉及
将优先考虑健康差距和医疗服务不足的人群,重点是实施。
PPP及其相关项目将支持多机构、多学科的合作
来自不同学术和文化背景的强大研究人员之间的研究。总的来说,这种方法
将建立一个基础广泛的全州研究平台,该平台有能力改善健康结果和
解决密西西比州各地的健康差异。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Celso Enrique Gomez-Sanchez其他文献
Celso Enrique Gomez-Sanchez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Celso Enrique Gomez-Sanchez', 18)}}的其他基金
Regulation of Mineralocorticoid Receptor Action
盐皮质激素受体作用的调节
- 批准号:
10436926 - 财政年份:2020
- 资助金额:
$ 76.25万 - 项目类别:
Regulation of Mineralocorticoid Receptor Action
盐皮质激素受体作用的调节
- 批准号:
10553631 - 财政年份:2020
- 资助金额:
$ 76.25万 - 项目类别:
Regulation of Mineralocorticoid Receptor Action
盐皮质激素受体作用的调节
- 批准号:
10293532 - 财政年份:2020
- 资助金额:
$ 76.25万 - 项目类别:
Adrenal cell ATP1A1 mutations and mechanisms of aldosterone biosynthesis
肾上腺细胞ATP1A1突变与醛固酮生物合成机制
- 批准号:
9981536 - 财政年份:2019
- 资助金额:
$ 76.25万 - 项目类别:
Adrenal cell ATP1A1 mutations and mechanisms of aldosterone biosynthesis
肾上腺细胞ATP1A1突变与醛固酮生物合成机制
- 批准号:
10210433 - 财政年份:2019
- 资助金额:
$ 76.25万 - 项目类别:
Adrenal cell ATP1A1 mutations and mechanisms of aldosterone biosynthesis
肾上腺细胞ATP1A1突变与醛固酮生物合成机制
- 批准号:
10447775 - 财政年份:2019
- 资助金额:
$ 76.25万 - 项目类别:
Adrenal cell ATP1A1 mutations and mechanisms of aldosterone biosynthesis
肾上腺细胞ATP1A1突变与醛固酮生物合成机制
- 批准号:
9813129 - 财政年份:2019
- 资助金额:
$ 76.25万 - 项目类别:
Regulation of the late-pathway of aldosterone biosynthesis
醛固酮生物合成后期途径的调节
- 批准号:
8254384 - 财政年份:2011
- 资助金额:
$ 76.25万 - 项目类别:
相似国自然基金
醛固酮瘤丙酸代谢异常通过MMA-肥大细胞-5-羟色胺-PCCA环路促进醛固酮合成的机制研究
- 批准号:82300887
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
卤代苯醌对肾素-血管紧张素-醛固酮系统的内分泌干扰作用及肾毒性机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
GNA11/GNAQ和CTNNB1双重突变导致醛固酮瘤和继发性高血压的发病机制探索
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
醛固酮诱导巨噬细胞极化-淋巴管内皮细胞样转化参与肾脏纤维化的机制及益气解毒化瘀中药的拮抗作用
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
醛固酮减弱血管内皮细胞时钟基因Bmal1震荡影响血压晨峰的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
相似海外基金
A Mentoring Program in Kidney Care for Older Adults
老年人肾脏护理指导计划
- 批准号:
10449851 - 财政年份:2022
- 资助金额:
$ 76.25万 - 项目类别:
Sex disparities in aldosterone-dependent renal Na+ transport and blood pressure control
醛固酮依赖性肾钠转运和血压控制的性别差异
- 批准号:
10298925 - 财政年份:2021
- 资助金额:
$ 76.25万 - 项目类别:
The Southeastern Acute Kidney Injury (SEAK) Alliance for the COPE-AKI Consortium
COPE-AKI 联盟东南部急性肾损伤 (SEAK) 联盟
- 批准号:
10296585 - 财政年份:2021
- 资助金额:
$ 76.25万 - 项目类别:
Mitochondrial redox regulation of adrenal steroidogenesis
线粒体氧化还原调节肾上腺类固醇生成
- 批准号:
10188802 - 财政年份:2021
- 资助金额:
$ 76.25万 - 项目类别: